Email UpdatesDate
The Consolidated Appropriations Act, 2023 reauthorizes major funding sources for substance use prevention, treatment, and recovery services and includes three bills that help facilitate the integration of behavioral health and primary care.
- The Medication Access and Training Expansion (MATE) Act (H.R. 2067 / S. 2235) requires all prescribers of federally controlled substances to complete 8 hours of training on treating and managing patients with opioid use disorder (OUD) and substance use disorder (SUD).
- The Mainstreaming Addiction Treatment (MAT) Act (H.R. 1384 / S. 445) eliminates the need for a separate waiver to dispense buprenorphine, a medication to treat OUD.
- The Collaborate in an Orderly and Cohesive Manner Act (H.R. 5218) provides grants and technical assistance for using the Collaborative Care Model to integrate behavioral health into primary care.
The Consolidated Appropriations Act, 2023 also has provisions for:
- Training, access, and education for naloxone, an opioid overdose reversing medication
- Establishing safe harbor to study contingency management, an effective behavioral health intervention for treating SUD
- Promoting mental health and substance use care for pregnant and postpartum individuals
- Enforcing compliance with mental health parity, which ensures that insurance coverage for substance use and mental health disorders is not more restrictive than insurance coverage for other medical conditions.
For more information on the Consolidated Appropriations Act, 2023, please see:
- Partnership to End Addiction - Consolidated Appropriations Act, 2023 Summary
- Shatterproof - President Joe Biden Signs Important Addiction Legislation
For more information on integrating behavioral health and primary care, please see:
- Academy for Integrating Behavioral Health and Primary Care – Playbooks and Substance Use Tools and Resources